JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
-5.95%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$78.8M
AUM Growth
+$78.8M
(-49%)
Cap. Flow
-$74.7M
Cap. Flow
% of AUM
-94.79%
Top 10 Holdings %
Top 10 Hldgs %
87.97%
Holding
60
New
1
Increased
5
Reduced
24
Closed
18
Top Buys
| 1 |
StoneCo
STNE
|
$11.5M |
| 2 |
S&P Global
SPGI
|
$892K |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$300K |
| 4 |
Agnico Eagle Mines
AEM
|
$179K |
| 5 |
Exxon Mobil
XOM
|
$63.7K |
Top Sells
| 1 |
XP
XP
|
$29.9M |
| 2 |
NGD
New Gold Inc
NGD
|
$7.22M |
| 3 |
Rhythm Pharmaceuticals
RYTM
|
$4.11M |
| 4 |
Nu Holdings
NU
|
$2.97M |
| 5 |
Inter&Co
INTR
|
$1.31M |
Sector Composition
| 1 | Technology | 30.81% |
| 2 | Financials | 22.95% |
| 3 | Healthcare | 19.21% |
| 4 | Materials | 1.15% |
| 5 | Energy | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
StoneCo
STNE
$4.41B
| $24.3M | 30.81% | 2,024,080 +958,380 | +90% | +$11.5M |
|
|
2
Nu Holdings
NU
$71.5B
| $15.8M | 20.11% | 1,229,300 -230,700 | -16% | -$2.97M |
|
|
3
S&P Global
SPGI
$167B
| $2.23M | 2.83% | 5,000 +2,000 | +67% | +$892K |
|
4
Eli Lilly
LLY
$657B
| $1.95M | 2.47% | 2,152 -25 | -1% | -$22.6K |
|
5
Incyte
INCY
$16.5B
| $1.91M | 2.42% | 31,434 -6 | -0% | -$364 |
|
|
ONC
6
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $1.49M | 1.9% | 10,464 -7 | -0.1% | -$999 |
|
7
UnitedHealth
UNH
$281B
| $1.22M | 1.55% | 2,401 -29 | -1% | -$14.8K |
|
8
Intuitive Surgical
ISRG
$170B
| $785K | 1% | 1,764 -21 | -1% | -$9.34K |
|
9
Thermo Fisher Scientific
TMO
$186B
| $768K | 0.97% | 1,388 -16 | -1% | -$8.85K |
|
10
Elevance Health
ELV
$71.8B
| $634K | 0.8% | 1,170 -14 | -1% | -$7.59K |
|
11
Merck
MRK
$210B
| $618K | 0.79% | 4,995 -58 | -1% | -$7.18K |
|
12
Acadia Pharmaceuticals
ACAD
$4.38B
| $597K | 0.76% | 36,740 -15 | -0% | -$244 |
|
13
Stryker
SYK
$150B
| $575K | 0.73% | 1,689 -20 | -1% | -$6.81K |
|
14
Vertex Pharmaceuticals
VRTX
$100B
| $490K | 0.62% | 1,046 -12 | -1% | -$5.63K |
|
15
Danaher
DHR
$147B
| $465K | 0.59% | 1,861 -22 | -1% | -$5.5K |
|
|
16
Agnico Eagle Mines
AEM
$72.4B
| $425K | 0.54% | 6,497 +2,732 | +73% | +$179K |
|
17
argenx
ARGX
$43.6B
| $381K | 0.48% | 887 -9 | -1% | -$3.87K |
|
18
Madrigal Pharmaceuticals
MDGL
$9.76B
| $373K | 0.47% | 1,333 | – | – |
|
19
AstraZeneca
AZN
$248B
| $361K | 0.46% | 4,631 -55 | -1% | -$4.29K |
|
|
20
Exxon Mobil
XOM
$487B
| $353K | 0.45% | 3,066 +553 | +22% | +$63.7K |
|
21
BioMarin Pharmaceuticals
BMRN
$11.2B
| $347K | 0.44% | 4,213 -12 | -0.3% | -$988 |
|
22
Regeneron Pharmaceuticals
REGN
$61.5B
| $346K | 0.44% | 329 -4 | -1% | -$4.2K |
|
23
Amgen
AMGN
$155B
| $327K | 0.42% | 1,048 -12 | -1% | -$3.75K |
|
|
24
Alnylam Pharmaceuticals
ALNY
$58.5B
| $300K | 0.38% | +1,233 | New | +$300K |
|
25
Alamos Gold
AGI
$12.8B
| $242K | 0.31% | 15,452 | – | – |
|